Guest guest Posted March 15, 2011 Report Share Posted March 15, 2011 Should patients with advanced cancers, have transfusions or other treatments to improve their blood levels (platelets, albumen and red blood cells) so they can enter clinical trials? Who's interest is being served? What is the therapeutic value? What does this do to the trial data? NEJM -http://www.nejm.org/doi/full/10.1056/NEJMc1008389 Article : http://www.medpagetoday.com/PublicHealthPolicy/ClinicalTrials/22886 ~chris Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.